XOMA Corporation

NASDAQ XOMAO

Data sourced from iex and EODHD
Download Data

XOMA Corporation Common Stock (Net) 3 year CAGR for the year ending December 31, 2020

XOMA Corporation Common Stock (Net) 3 year CAGR is NA for the year ending December 31, 2020. Common Stock (Net) is the net value of the company's common stock after deducting any repurchased shares or treasury stock. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • XOMA Corporation Common Stock (Net) for the year ending December 31, 2020 was USD 84.00 K, a 15.07% change year over year.
  • XOMA Corporation Common Stock (Net) for the year ending December 31, 2019 was USD 73.00 K.
NASDAQ: XOMAO

XOMA Corporation

CEO -
IPO Date April 12, 2021
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAP

XOMA Corp

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email